Acetazolamide Market Size And Forecast
Global Acetazolamide Market was valued at USD 182.3 Million in 2018 and is projected to reach USD 262.01 Billion by 2026, growing at a CAGR of 4.6% from 2023 to 2032.
A carbonic anhydrase inhibitor called acetazolamide is used to lower ocular pressure in persons with specific kinds of glaucoma. It can also be applied to treat epilepsy on occasion. The increasing demand for this product among glaucoma patients, who account for the majority of cases of irreversible blindness worldwide, is the main factor fueling growth of the global acetazolamide market.
Acetazolamide, a carbonic anhydrase inhibitor, is used to treat acute angle-closure glaucoma, epilepsy, edoema brought on by congestive heart failure, drug-induced edoema, and acute mountain sickness in climbers as well as in the adjuvant treatment of chronic simple (open-angle) glaucoma and secondary glaucoma. Acetazolamide produces metabolic acidosis, boosts bicarbonate secretion by the kidneys, aids in adaptation to altitude, and facilitates breathing. Additionally, acetazolamide in doses of 250 mg, 500 mg, and 750 mg daily is superior to a placebo for preventing acute mountain sickness, according to the BMJ Journal, September 2012. The lowest effective dose of acetazolamide to prevent acute mountain sickness is 250 mg per day.
Most people use acetazolamide to prevent high altitude illness, which is sometimes referred to as acute mountain sickness and is characterised by headache, nausea, vomiting, and fatigue, but can also affect the brain or the lungs in some people. Acetazolamide is a more effective and superior treatment than a placebo for the prevention of acute high altitude illness (HAI), according to a study published in the Cochrane Journal in June 2017. In comparison to alternative medications like dexamethasone, acetazolamide avoids acute mountain sickness and has less adverse effects. Acetazolamide prescriptions for travel are an optional service and are not covered by the general practitioner’s contract in the UK, according to BMJ journal, May 2018.
Strategic insights into the competitive environment of the global acetazolamide market are provided in the study titled “Global Acetazolamide Market – Competitive Portfolio, Market Share, Business Strategy, and Developments, 2022-2032.” The report will provide a company overview for each major player operating in the global acetazolamide market while taking into account factors such as the company’s global sales network, employee strength, key executives, stock exchange listing, subsidiaries, R&D endeavours, and manufacturing portfolio. For instance, Teva Pharmaceutical Industries Ltd. spent US$ 1.8 billion on research and development in 2017, demonstrating a strong focus on improving its market position. Revenue from the global acetazolamide market, which was 190.3 million US dollars in 2017, is anticipated to grow at a CAGR of 5.1% from 2019 to 2024.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Acetazolamide manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Acetazolamide market covering all its essential aspects.
Click Here To Access The Free Sample Report @ https://analyticsmarketresearch.com/sample-request/acetazolamide-market/48897/
Global Acetazolamide Market: Segmentations
Global Acetazolamide Market: By Key Players
Teva
TARO
Zydus Pharmaceuticals
Lannett Company
Sun Pharmaceutical
Heritage Pharmaceuticals
Nostrum Laboratories
Accord Healthcare
Strides Pharma
West-Ward Pharmaceuticals
X-Gen Pharmaceuticals
Mylan
Emcure
Global Acetazolamide Market: By Types
Tablets
Capsule
Injection
Global Acetazolamide Market: By Applications
Hospital
Drug Store
Global Acetazolamide Market: Regional Analysis
The countries covered in the regional analysis of the Global Acetazolamide market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Read Full Research Report @ https://analyticsmarketresearch.com/reports/acetazolamide-market/48897/
Global Acetazolamide Market Competitive Landscape
With a focus on the global market and some of the key players like Novast Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Strides Shasun Limited, Accord Healthcare Ltd. (Intas Pharmaceuticals Limited), Nostrum Laboratories Inc., Heritage Pharmaceuticals Inc., Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.), X-GEN Pharmaceuticals, Inc., and Lannett Company, Inc., the “Global Acetazolamide Market” study report Our market analysis includes a section specifically devoted to such large firms, where our analysts give an overview of each player’s financial statements, along with product benchmarking and SWOT analysis. Key development strategies, market share analysis, and market positioning analysis of the aforementioned competitors internationally are also included in the competitive landscape section.
An Overview of the Impact of COVID-19 on Market: The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Frequently Asked Questions
- What are the growth estimates for acetazolamide market till 2026?
- Which are the prominent market players across the globe?
- Which segment based on formulation, accounted for the highest demand in the acetazolamide market?
- What are the key factors driving growth of the acetazolamide market?
- What is the Compound Annual Growth Rate (CAGR) of the acetazolamide market for next 8 years?
- Which region is dominating the acetazolamide market growth?
Check Our More Report On Healthcare And Science:
Global Pharmacovigilance Market – https://analyticsmarketresearch.com/reports/pharmacovigilance-market/287/
Global Suture Anchor Market – https://analyticsmarketresearch.com/reports/suture-anchor-market/302/
About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: sales@analyticsmarketresearch.com
